The long term objective of this proposal is to evaluate the potential contribution of the """"""""activated"""""""" alveolar macrophage (A-Mo) in producing the lung injury that commonly complicates recovery from severe trauma or burns. In this clinical setting, the patients are frequently septic with a concomitant endotoxemia and/or sustained for prolonged periods with high FI02 ventilation to correct hypoxemia. Both endotoxin (LPS) and oxygen metabolites are known to stimulate Mo and are also associated with acute lung injury. A-Mo will be stimulated with LPS and 02 intermediates both in vitro and in vivo and the ability of A-Mo to produce: 1) procoagulant activity, 2) cytotoxic agents, and 3) fibroblast growth factor(s) will be confirmed in vitro and the in vivo. Attempts will then be made to block these products in vitro, utilizing agents from one of three groups known to modulate Mo functions: 1) corticosteroids, 2) non-steroidal anti-inflammatory drugs (NSAID) and 3) scavengers of O2 intermediates. The inhibitors of mediator production in vitro will then be tested in vivo. Potential amelioration of lung injury will be correlated with microscopic (light and electron) and pulmonary hemodynamic and respiratory changes (utilizing a chronic lung lymph fistula) between inhibitor pretreated and untreated animals. The goal is thus to confirm the association of the production of deleterious mediators by A-Mo and acute lung injury, and correlate inhibition of these products with an amelioration of the acute lung injury by both anatomic and physiologic criteria.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM035361-01A1
Application #
3287963
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1986-04-01
Project End
1991-03-31
Budget Start
1986-04-01
Budget End
1987-03-31
Support Year
1
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Williams, J G; Jurkovich, G J; Maier, R V (1993) Interferon-gamma: a key immunoregulatory lymphokine. J Surg Res 54:79-93
Williams, J G; Garcia, I; Maier, R V (1993) Prostaglandin E2 mediates lipopolysaccharide-induced macrophage procoagulant activity by a cyclic adenosine monophosphate-dependent pathway. Surgery 114:314-23
Williams, J G; Jurkovich, G J; Hahnel, G B et al. (1992) Macrophage priming by interferon gamma: a selective process with potentially harmful effects. J Leukoc Biol 52:579-84
Maier, R V; Hahnel, G B; Fletcher, J R (1992) Platelet-activating factor augments tumor necrosis factor and procoagulant activity. J Surg Res 52:258-64
Simons, R K; Maier, R V; Chi, E Y (1991) Pulmonary effects of continuous endotoxin infusion in the rat. Circ Shock 33:233-43
Maier, R V; Hahnel, G B; Pohlman, T H (1990) Endotoxin requirements for alveolar macrophage stimulation. J Trauma 30:S49-57
Magnuson, D K; Weintraub, A; Pohlman, T H et al. (1989) Human endothelial cell adhesiveness for neutrophils, induced by Escherichia coli lipopolysaccharide in vitro, is inhibited by Bacteroides fragilis lipopolysaccharide. J Immunol 143:3025-30
Magnuson, D K; Maier, R V; Pohlman, T H (1989) Protein kinase C: a potential pathway of endothelial cell activation by endotoxin, tumor necrosis factor, and interleukin-1. Surgery 106:216-22;discussion 222-3